Disparities in treatment of lung cancer patients

8th March 2018

Recent research suggests disparities in treatment across English could be resulting in hundreds of lung cancer patients dying early each year.

Christian Beadell, a senior solicitor within our medical negligence department, commented on the news, “This review is based on a large study group and it’s findings need to be taken seriously. It will be of immense concern to patients that there is such a significant disparity between survival rates at different Trusts. It is hard to understand how this can arise if all Trusts are adopting an evidence based approach in line with NICE (National Institute for Clinical Excellence) guidance. The Trusts that adopted a more proactive and aggressive treatment plan were associated with better survival rates. Whilst this would seem to be a fairly obvious conclusion, it will be interesting to see if the differing approaches are due to variance in local Protocols or simply rationing decisions based on funding.

As patients are rarely aware of the approach that their Trust adopts, it will be interesting to see if this report leads to an increasing number of requests for out of area referrals by patients who understandably would want to be treated by a Trust showing better survival rates.”

You can read the full article here.



Further Reading…

Comment: It’s time to take Sepsis more seriously

5th July 2019

Fletchers Solicitors Litigation Executive, Daniel Crowder believes those affected by Sepsis must speak out against the ‘hidden killer.’ Only last week, the London Evening Standard reported that a mum-of-two died…

You don't have to go through this alone - take the first step now

  • IIP - Investors in People
  • The Sunday Times Top 100 - Best Companies To Work For 2016
  • The Investors In People Awards 2016 - Winner
  • The Legal 500 - Leading Firm 2015
  • The Law Society - Clinical Negligence
  • The Lawyer UK200 - Listed Firm 2015
  • Top Ranked Leading Individual - Chambers UK 2019